Entellus Medical (ENTL) Announces Publication of Positive XprESS Balloon SDS Study Data
Tweet Send to a Friend
Entellus Medical, Inc. (Nasdaq: ENTL) announced that the results of a prospective, multicenter clinical study using the Company’s XprESS balloon ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
